Ricky D Shafer

Array ( [id] => 3049277 [patent_doc_number] => 05283172 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-02-01 [patent_title] => 'Type-C rotavirus cultures and uses therefor' [patent_app_type] => 1 [patent_app_number] => 7/904726 [patent_app_country] => US [patent_app_date] => 1992-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8919 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/283/05283172.pdf [firstpage_image] =>[orig_patent_app_number] => 904726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3074896 [patent_doc_number] => 05322769 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-06-21 [patent_title] => 'Methods for using CKS fusion proteins' [patent_app_type] => 1 [patent_app_number] => 7/903043 [patent_app_country] => US [patent_app_date] => 1992-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 19 [patent_no_of_words] => 14875 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/322/05322769.pdf [firstpage_image] =>[orig_patent_app_number] => 903043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3471539 [patent_doc_number] => 05476765 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-12-19 [patent_title] => 'Synthetic peptide compositions with immunoreactivities to antibodies to HTLV and as vaccines' [patent_app_type] => 1 [patent_app_number] => 7/901874 [patent_app_country] => US [patent_app_date] => 1992-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11494 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/476/05476765.pdf [firstpage_image] =>[orig_patent_app_number] => 901874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2968440 [patent_doc_number] => 05258369 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-11-02 [patent_title] => 'Treatment of chronic cerebral dysfunction by dsRNA methodology' [patent_app_type] => 1 [patent_app_number] => 7/899004 [patent_app_country] => US [patent_app_date] => 1992-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2647 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/258/05258369.pdf [firstpage_image] =>[orig_patent_app_number] => 899004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3070717 [patent_doc_number] => 05360736 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-11-01 [patent_title] => 'Process for attenuated varicella zoster virus vaccine production' [patent_app_type] => 1 [patent_app_number] => 7/893295 [patent_app_country] => US [patent_app_date] => 1992-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11320 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 198 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/360/05360736.pdf [firstpage_image] =>[orig_patent_app_number] => 893295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3073369 [patent_doc_number] => 05296383 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-03-22 [patent_title] => 'Human centromere antigen polypeptide' [patent_app_type] => 1 [patent_app_number] => 7/879685 [patent_app_country] => US [patent_app_date] => 1992-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6419 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/296/05296383.pdf [firstpage_image] =>[orig_patent_app_number] => 879685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2999312 [patent_doc_number] => 05359031 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-10-25 [patent_title] => 'Unique protein marker for bladder cancer' [patent_app_type] => 1 [patent_app_number] => 7/875626 [patent_app_country] => US [patent_app_date] => 1992-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 9 [patent_no_of_words] => 9660 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/359/05359031.pdf [firstpage_image] =>[orig_patent_app_number] => 875626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3063452 [patent_doc_number] => 05307402 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-04-26 [patent_title] => 'Reduced time remote access method' [patent_app_type] => 1 [patent_app_number] => 7/860497 [patent_app_country] => US [patent_app_date] => 1992-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9261 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/307/05307402.pdf [firstpage_image] =>[orig_patent_app_number] => 860497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3049364 [patent_doc_number] => 05283177 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-02-01 [patent_title] => 'Placental isoferritins for the prognosis and diagnosis of immunosuppression' [patent_app_type] => 1 [patent_app_number] => 7/853462 [patent_app_country] => US [patent_app_date] => 1992-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 13262 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/283/05283177.pdf [firstpage_image] =>[orig_patent_app_number] => 853462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3766651 [patent_doc_number] => 05849477 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Assays of coup transcription factor interactions in mammalian systems' [patent_app_type] => 1 [patent_app_number] => 7/852731 [patent_app_country] => US [patent_app_date] => 1992-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 5542 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849477.pdf [firstpage_image] =>[orig_patent_app_number] => 852731 [rel_patent_id] =>[rel_patent_doc_number] =>)